ID AK1H_SERMA Reviewed; 819 AA. AC P27725; Q59936; Q59937; Q60127; Q60157; DT 01-AUG-1992, integrated into UniProtKB/Swiss-Prot. DT 01-AUG-1992, sequence version 1. DT 04-NOV-2008, entry version 64. DE RecName: Full=Bifunctional aspartokinase/homoserine dehydrogenase 1; DE AltName: Full=Aspartokinase I/homoserine dehydrogenase I; DE Short=AKI-HDI; DE Includes: DE RecName: Full=Aspartokinase; DE EC=2.7.2.4; DE Includes: DE RecName: Full=Homoserine dehydrogenase; DE EC=1.1.1.3; GN Name=thrA; Synonyms=thrA1, thrA2; OS Serratia marcescens. OC Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales; OC Enterobacteriaceae; Serratia. OX NCBI_TaxID=615; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=Sr41 / 8000, Sr41 / HNr21, Sr41 / HNr59, and Sr41 / TLr156; RX MEDLINE=93139048; PubMed=8423151; RA Omori K., Suzuki S., Komatsubara S.; RT "Nucleotide sequence of the Serratia marcescens threonine operon and RT analysis of the threonine operon mutations which alter feedback RT inhibition of both aspartokinase I and homoserine dehydrogenase I."; RL J. Bacteriol. 175:785-794(1993). CC -!- CATALYTIC ACTIVITY: L-homoserine + NAD(P)(+) = L-aspartate 4- CC semialdehyde + NAD(P)H. CC -!- CATALYTIC ACTIVITY: ATP + L-aspartate = ADP + 4-phospho-L- CC aspartate. CC -!- ENZYME REGULATION: The enzyme activities are regulated CC allosterically by L-threonine. CC -!- PATHWAY: Amino-acid biosynthesis; L-lysine biosynthesis via DAP CC pathway; tetrahydrodipicolinate from L-aspartate: step 1/4. CC -!- PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via de CC novo pathway; L-homoserine from L-aspartate: step 1/3. CC -!- PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via de CC novo pathway; L-homoserine from L-aspartate: step 3/3. CC -!- PATHWAY: Amino-acid biosynthesis; L-threonine biosynthesis; L- CC threonine from L-aspartate: step 1/5. CC -!- PATHWAY: Amino-acid biosynthesis; L-threonine biosynthesis; L- CC threonine from L-aspartate: step 3/5. CC -!- SUBUNIT: Homotetramer. CC -!- SIMILARITY: In the N-terminal section; belongs to the CC aspartokinase family. CC -!- SIMILARITY: In the C-terminal section; belongs to the homoserine CC dehydrogenase family. CC -!- SIMILARITY: Contains 2 ACT domains. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; D10385; BAA38474.1; -; Genomic_DNA. DR EMBL; D10386; BAA38477.1; -; Genomic_DNA. DR EMBL; D10387; BAA38480.1; -; Genomic_DNA. DR EMBL; X60821; CAA43212.1; -; Genomic_DNA. DR PIR; B47057; B47057. DR HSSP; P31116; 1EBF. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR GO; GO:0009088; P:threonine biosynthetic process; IEA:UniProtKB-KW. DR InterPro; IPR002912; ACT_bd. DR InterPro; IPR001048; Asp/Glu/Uridylate_kinase. DR InterPro; IPR005106; Asp/hSer_DHase_NAD-bd. DR InterPro; IPR001341; Asp_kin_reg. DR InterPro; IPR011147; bifunc_aspartokin/hSer_DHase. DR InterPro; IPR001342; hSer_DHase_cat. DR InterPro; IPR016040; NAD(P)-bd. DR Gene3D; G3DSA:3.40.1160.10; Aa_kinase; 1. DR Gene3D; G3DSA:3.40.50.720; NAD(P)-bd; 1. DR Pfam; PF00696; AA_kinase; 1. DR Pfam; PF01842; ACT; 2. DR Pfam; PF00742; Homoserine_dh; 1. DR Pfam; PF03447; NAD_binding_3; 1. DR PIRSF; PIRSF000727; ThrA; 1. DR TIGRFAMs; TIGR00657; asp_kinases; 1. DR PROSITE; PS00324; ASPARTOKINASE; 1. DR PROSITE; PS01042; HOMOSER_DHGENASE; 1. PE 3: Inferred from homology; KW Allosteric enzyme; Amino-acid biosynthesis; Kinase; KW Multifunctional enzyme; NADP; Oxidoreductase; Repeat; KW Threonine biosynthesis; Transferase. FT CHAIN 1 819 Bifunctional aspartokinase/homoserine FT dehydrogenase 1. FT /FTId=PRO_0000066682. FT DOMAIN 316 385 ACT 1. FT DOMAIN 397 468 ACT 2. FT NP_BIND 471 478 NADP (Potential). FT REGION 1 249 Aspartokinase (By similarity). FT REGION 250 470 Interface (By similarity). FT REGION 471 819 Homoserine dehydrogenase (By similarity). FT VARIANT 330 330 G -> D (in strain: Sr41 / 8000, Sr41 / FT HNr21; loss of feedback inhibition). FT VARIANT 352 352 S -> F (in strain: Sr41 / TLr156; loss of FT feedback inhibition). FT VARIANT 479 479 A -> T (in strain: Sr41 / HNr59; Thr- FT resistant HDI). SQ SEQUENCE 819 AA; 88495 MW; 1F18552B036A8E39 CRC64; MRVLKFGGTS VANAERFLRV ADIMESNARQ GQVATVLSAP AKITNHLVAM IDKTVAGQDI LPNMSDAERI FADLLSGLAQ ALPGFEYDRL KGVVDQEFAQ LKQVLHGVSL LGQCPDSVNA AIICRGEKLS IAIMEGVFRA KGYPVTVINP VEKLLAQGHY LESTVDIAES TLRIAAAAIP ADHIVLMAGF TAGNDKGELV VLGRNGSDYS AAVLAACLRA DCCEIWTDVD GVYTCDPRTV PDARLLKSMS YQEAMELSYF GAKVLHPRTI TPIAQFQIPC LIKNTSNPQA PGTLIGKDST DADMPVKGIT NLNNMAMINV SGPGMKGMVG MAARVFAVMS RAGISVVLIT QSSSEYSISF CVPQGELQRA RRALEEEFYL ELKDGVLDPL DVMERLAIIS VVGDGMRTLR GISARFFSAL ARANINIVAI AQGSSERSIS VVVSNDSATT GVRVSHQMLF NTDQVIEVFV IGVGGVGGAL IEQIYRQQPW LKQKHIDLRV CGIANSRVML TNVHGIALDS WRDALAGAQE PFNLGRLIRL VKEYHLLNPV IVDCTSSQAV ADQYVDFLAD GFHVVTPNKK ANTSSMNYYQ QLRAAAAGSH RKFLYDTNVG AGLPVIENLQ NLLNAGDELV RFSGILSGSL SFIFGKLDEG LSLSAATLQA RANGYTEPDP RDDLSGMDVA RKLLILAREA GYKLELSDIE VEPVLPPSFD ASGDVDTFLA RLPELDKEFA RNVANAAEQG KVLRYVGLID EGRCKVRIEA VDGNDPLYKV KNGENALAFY SRYYQPLPLV LRGYGAGNDV TAAGVFADLL RTLSWKLGV //